Apogee and Sagimet’s IPO plans come into view, with targeted raises of $228M and $66M
Apogee Therapeutics and Sagimet Biosciences offered new details on their IPO plans Monday morning, saying they look to raise $228 million and $66 million in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
